SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
InterMune (nasdaq)ITMN
An SI Board Since March 2000
Posts SubjectMarks Bans Symbol
508 36 0 ITMN
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
283This is a tough one, I've decided that it is too tough to play given the optjayhawk969-8/26/2002
282Wilder, AH&H had this in the report: "Top-line data from the Phase JFitnich-8/26/2002
281Is that right...before or after <i>Labor Day</i>? I had heard resulkeokalani'nui-8/26/2002
280Nice balance. It's Make-or-Break Time for Intermune By Adam Feuerstein rkrw-8/26/2002
279Options on 8/23: Still active but not at the frenzy level we saw a few days agoIRWIN JAMES FRANKEL-8/24/2002
278Options today: Sept Calls (contracts, strike, close) 176 22.5 3.60 1542 25 IRWIN JAMES FRANKEL-8/20/2002
277Institutional holdings have been mostly updated through 6/30. There are a few nIRWIN JAMES FRANKEL-8/17/2002
276I've wondered about the .05 value myself. I understand why you would want aMichael Young-8/9/2002
275Can you share some of your anecdotal experiences? One Dr. I spoke with recentlrkrw-8/9/2002
274I think a way to look at it L (assume p<.05) is "there's a less thanrkrw-8/9/2002
273It works VERY WELL, the study results will be out within a few more weeks but I Secret_Agent_Man-8/8/2002
272P values - a dumb question: Attaining a P value of .05 or less is the standard IRWIN JAMES FRANKEL-8/8/2002
271Just playing around. Actimmune Revenue Est: 3Q ... $28.6 M 4Q ... 36.3 M LosIRWIN JAMES FRANKEL-8/8/2002
270A little comparison game: 2002 SCIO Natrecor expectations: $90-95M 2002 ITMN Arkrw-7/30/2002
269Biotechs typically trade flat to down prior to release of critical Phase III datMichael Young-7/29/2002
268RC, The co is planning to release top line results by early or mid September. rkrw-7/29/2002
267<i>data release in September</i> September? I had thought it was scRCMac-7/29/2002
266Good point rkrw, Some short covering could help drive the surge to 40 that I exIRWIN JAMES FRANKEL-7/29/2002
265Days short outstanding is increasing as avg volume has declined by 2/3 over the rkrw-7/29/2002
264Small increase in short interest compared to other bios I follow: Jul. 15, 2002IRWIN JAMES FRANKEL-7/29/2002
263>> I'm impressed even if you are not. << I am, I am! >> scaram(o)uche-7/18/2002
262Well Harmon, I'm impressed even if you are not. But then I am impressed wiIRWIN JAMES FRANKEL-7/18/2002
261>> My guess $22.5 to $23 million << Low end of range....... $22.6scaram(o)uche-7/18/2002
260Tomorrow we should see what 2Q Actimmune sales are. My guess $22.5 to $23 milIRWIN JAMES FRANKEL-7/17/2002
259My thanks to RCMac, copied from Yahoo: In my earlier post I paraphrased clinicaIRWIN JAMES FRANKEL-7/16/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News